Delivery Order SPE2DB22D3501-SPE2DB26FTH87
- Not listed
- The Defense Logistics Agency awarded a $29.3K delivery order to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack unit dose systems on October 22, 2025, with completion targeted for October 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a $26,633.16 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Spravato 84 mg dose pack UDS (unit dose systems). The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded without set-aside provisions. Performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack units of use, valued at $11,134.62 on October 24, 2025, with an ultimate completion date of October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,904.65 on May 27, 2025, for the supply of Spravato 84 mg dose pack unit dose systems (UDS). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Spravato is an FDA-approved nasal spray medication primarily used for treatment-resistant depression, making this a specialized...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,829.09 to AmerisourceBergen Drug Corp for the supply of SPRAVATO 84 mg dose pack UDS (unit dose packages). This firm fixed price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a prescription nasal spray used in treating...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of SPRAVATO 84 MG DOSE PACK medical supplies. The order, valued at $22,963.32, has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any specific business type. Amerisourcebergen Drug Corp also...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Spravato 56 mg dose packs, a medication used to treat depression. The contract has a firm fixed price, with a ceiling value of $4,087.55 and a period of performance through April 16, 2025. This order is not set aside for any specific business type. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,688 to Amerisourcebergen Drug Corporation to supply 4561933884 units of 56 mg doses of Spravato. As the prime contractor, Amerisourcebergen will deliver the medication to a location in Conshohocken, Pennsylvania by August 25, 2023 under the contract start and end dates. The Defense Logistics Agency is the funding agency for this requirement to support its medical supply chain initiatives. No...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,622.08 contract is for the supply of SPRAVATO 84 MG DOSE PACK UDS, a specialty medication. The contract has a period of performance through September 13, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, such as a $999,999,999 DLA Troop Support Medical IDC and a $750,000...
- The Defense Logistics Agency awarded a $7,132 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 84 mg doses of SPRAVATO (esketamine) nasal spray. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 21-22, 2023. No subcontractors or set aside designations were identified. This order supports DLA's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTH87Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,212.06 to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack unit dose systems (UDS) on October 30, 2025, with completion targeted for October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania, where the company maintains its primary distribution operations. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving the federal medical procurement system, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. As a prime contractor on the DLA Troop Support Medical global pharmaceutical support contract, the company supplies a comprehensive range of pharmaceutical products and medical devices across multiple therapeutic domains. Spravato (esketamine) is a specialized neurological treatment indicated for treatment-resistant depression, and this delivery order represents one of numerous competitively awarded orders the company fulfills for federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, under its comprehensive global pharmaceutical prime vendor vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/30/25 |